Anticoagulation Therapy for Patients with Non-Valvular Atrial Fibrillation

The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation

(2013) Daniel E. Singer   ANNALS OF INTERNAL MEDICINE

Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable

(2013) Stuart J. Connolly   ANNALS OF INTERNAL MEDICINE

Antithrombotic Therapy for Atrial Fibrillation

(2012) John J. You et al.   CHEST

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

(2012) Leif Friberg et al.   EUROPEAN HEART JOURNAL

Putting risk prediction in atrial fibrillation into perspective

(2012) Jonathan P. Piccini et al.   EUROPEAN HEART JOURNAL

Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation

(2011) Shimoli V. Shah et al.   CIRCULATION

A New Risk Scheme to Predict Warfarin-Associated Hemorrhage

(2011) Margaret C. Fang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Total costs and atrial fibrillation ablation success or failure in medicare-aged patients in the United States

(2010) Michael H. Kim et al.   ADVANCES IN THERAPY

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?

(2010) Peter J. Zimetbaum et al.   AMERICAN JOURNAL OF MEDICINE

Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

(2010) Isla M. Ogilvie et al.   AMERICAN JOURNAL OF MEDICINE

Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation

(2010) Margaret C. Fang et al.  

Moving the Tipping Point

(2010) Mark H. Eckman et al.  

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

Stroke Prevention and Treatment

(2010) James D. Marsh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Age- and Gender-Specific Prevalence of Cardiovascular Risk Factors in 40 102 Patients With First-Ever Ischemic Stroke

(2010) Klaus Kaae Andersen et al.   STROKE

Cost-effectiveness of warfarin: Trial versus “real-world” stroke prevention in atrial fibrillation

(2009) Sonja V. Sorensen et al.   AMERICAN HEART JOURNAL

Increasing Prevalence of Atrial Fibrillation and Flutter in the United States

(2009) Gerald V. Naccarelli et al.   AMERICAN JOURNAL OF CARDIOLOGY

Pharmacotherapy for the Secondary Prevention of Stroke

(2009) Kazunori Toyoda   DRUGS

Antithrombotic Therapy in Atrial Fibrillation

(2008) Daniel E. Singer et al.   CHEST